<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04159714</url>
  </required_header>
  <id_info>
    <org_study_id>18-009586</org_study_id>
    <nct_id>NCT04159714</nct_id>
  </id_info>
  <brief_title>Bandage Contact Lens Application for the Management of Corneal Abrasion</brief_title>
  <official_title>Bandage Contact Lens Application for the Management of Corneal Abrasion in the Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The researchers are trying to understand if the application of a bandage contact lens results
      in better relief than usual treatment for a corneal abrasion.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 10, 2019</start_date>
  <completion_date type="Anticipated">December 10, 2024</completion_date>
  <primary_completion_date type="Anticipated">September 10, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in pain score</measure>
    <time_frame>Baseline, approx. 12-24 hours, approx. 36-48 hours, approx. 1 day, 3 days, and/or 5 days post-discharge</time_frame>
    <description>Measured on scale of 0 being no pain, 5 being moderate pain and 10 being worst pain possible</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Corneal Abrasion</condition>
  <arm_group>
    <arm_group_label>Bandage Contact Lens (BCL) group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects diagnosed with superficial corneal abrasion in the Emergency Department will have a bandage contact lens soaked in antibiotic solution placed in the affected eye</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects diagnosed with superficial corneal abrasion in the Emergency Department will have usual care provided in the Emergency Department</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Air Optix contact lens</intervention_name>
    <description>Contact lens will be placed on the surface of the patient's eye and is to be used as a bandage</description>
    <arm_group_label>Bandage Contact Lens (BCL) group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of Superficial Corneal Abrasion

        Exclusion Criteria:

          -  Incarceration

          -  Pregnancy

          -  Inability to Provide Informed Consent

          -  Infectious keratitis

          -  Retained foreign bodies in the eye

          -  Active infection involving the orbit or periorbital region

          -  Patients who are not able to or who are deemed unlikely to follow-up with
             ophthalmology

          -  A history or recent contact lens wear

          -  A lack of trauma or an unclear history of trauma as the inciting cause of the abrasion

          -  Allergy to the antimicrobial solution (POLYTRIM)

          -  Women who are currently breastfeeding

          -  Chronic eye drop use

          -  A history of eye surgery other than cataract surgery (greater than 6 months prior to
             abrasion)

          -  Diabetes (Patients with even mild diabetic neuropathy can have decreased pain
             sensation and also delayed corneal epithelial healing)

          -  Any eye condition that may be deemed to interfere with the conduct of the protocol or
             outcome measurement.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Hyde</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaitlin Lundell</last_name>
      <phone>507-255-5056</phone>
      <email>Lundell.Kaitlin@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Hyde, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 8, 2019</study_first_submitted>
  <study_first_submitted_qc>November 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 12, 2019</study_first_posted>
  <last_update_submitted>November 8, 2019</last_update_submitted>
  <last_update_submitted_qc>November 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Robert J. Hyde</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

